omniture
logo
Search
CLARITY PHARMACEUTICALS
Media Room

Photo News

rss
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

2024-03-08 22:02 1685
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

2023-11-30 21:59 1332
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial

First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial

2023-08-25 20:58 2511
Clarity's theranostic prostate cancer trial advances to cohort 2

Clarity's theranostic prostate cancer trial advances to cohort 2

2023-05-24 21:03 2525
Fifty percent recruitment milestone for PROPELLER prostate cancer trial

Fifty percent recruitment milestone for PROPELLER prostate cancer trial

2021-12-01 21:57 1454
Recruitment for the dosimetry phase of Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial completed

Recruitment for the dosimetry phase of Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial completed

2021-11-10 22:06 1580